Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Predictors of Grade Group Upgrading for Radical Prostatectomy Specimens Compared to Those of Preoperative Needle Biopsy Specimens.
Tomioka M, Saigo C, Kawashima K, Suzui N, Miyazaki T, Takeuchi S, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Nakane K, Takeuchi T, Koie T. Tomioka M, et al. Among authors: takai m. Diagnostics (Basel). 2022 Nov 11;12(11):2760. doi: 10.3390/diagnostics12112760. Diagnostics (Basel). 2022. PMID: 36428820 Free PMC article.
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study.
Iinuma K, Tomioka-Inagawa R, Kameyama K, Taniguchi T, Kawada K, Ishida T, Nagai S, Enomoto T, Ueda S, Kawase M, Takeuchi S, Kawase K, Kato D, Takai M, Nakane K, Koie T. Iinuma K, et al. Among authors: takai m. Biomedicines. 2022 Dec 7;10(12):3172. doi: 10.3390/biomedicines10123172. Biomedicines. 2022. PMID: 36551927 Free PMC article.
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study.
Iinuma K, Yamada T, Kameyama K, Taniguchi T, Kawada K, Ishida T, Nagai S, Enomoto T, Ueda S, Takagi K, Kawase M, Takeuchi S, Kawase K, Kato D, Takai M, Nakane K, Koie T. Iinuma K, et al. Among authors: takai m. Cancers (Basel). 2023 Feb 2;15(3):947. doi: 10.3390/cancers15030947. Cancers (Basel). 2023. PMID: 36765903 Free PMC article.
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.
Sugino F, Nakane K, Kawase M, Ueda S, Tomioka M, Takeuchi Y, Tomioka-Inagawa R, Yamada T, Namiki S, Kumada N, Takeuchi S, Kawase K, Kato D, Takai M, Iinuma K, Tobisawa Y, Koie T. Sugino F, et al. Among authors: takai m. Life (Basel). 2023 Apr 23;13(5):1072. doi: 10.3390/life13051072. Life (Basel). 2023. PMID: 37240717 Free PMC article.
[A Case of Refractory Lymphatic Leakage after Robot-Assisted Radical Cystectomy].
Namiki S, Ueda S, Takeuchi Y, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Nakane K, Nagata S, Kawada H, Matsuo M, Koie T. Namiki S, et al. Among authors: takai m. Hinyokika Kiyo. 2023 May;69(5):137-142. doi: 10.14989/ActaUrolJap_69_5_137. Hinyokika Kiyo. 2023. PMID: 37312494 Free article. Japanese.
549 results